Case Conclusion Date:January 1, 2008
Practice Area:Patent Infringement
Outcome:Trial verdict, affirmed on appeal
Description:Secured trial verdict and permanent injunction in favor of Takeda Pharmaceutical Company Ltd. in Hatch-Waxman litigation to protect PREVACID® (lansoprazole) from a challenge by Teva, the world’s largest generic pharmaceutical company. PREVACID, a proton pump inhibitor, was one of the top-10 selling drugs in the world with annual sales in excess of $4 billion.